British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve

Objectives The aim of this work was to audit the extent to which routine HIV care in the UK conforms with British HIV Association (BHIVA) guidelines and specifically the proportion of patients starting highly active antiretroviral therapy (HAART) who achieve the outcome of virological suppression be...

Full description

Saved in:
Bibliographic Details
Published in:HIV medicine 2009-07, Vol.10 (6), p.337-342
Main Authors: Street, E, Curtis, H, Sabin, CA, Monteiro, EF, Johnson, MA
Format: Article
Language:English
Subjects:
Adult
Anti-HIV Agents - therapeutic use
Antiretroviral Therapy, Highly Active
antiretroviral treatment
audit
CD4 Lymphocyte Count - methods
Early Diagnosis
Female
Guideline Adherence - standards
HAART
HIV Infections - diagnosis
HIV Infections - drug therapy
HIV-1
HIV‐1 viral load
Human immunodeficiency virus 1
Humans
Longitudinal Studies
Male
Medical Audit
outcomes
Prospective Studies
United Kingdom
Viral Load
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The aim of this work was to audit the extent to which routine HIV care in the UK conforms with British HIV Association (BHIVA) guidelines and specifically the proportion of patients starting highly active antiretroviral therapy (HAART) who achieve the outcome of virological suppression below 50 HIV‐1 RNA copies/mL within 6 months. Methods A prospective cohort review of adults with HIV infection who started antiretroviral therapy (ART) for the first time between April and September 2006 was carried out using structured questionnaire forms. Results A total of 1170 adults from 122 clinical sites participated in the review. Of these patients, 699 (59.7%) started ART at CD4 counts
ISSN:1464-2662
1468-1293
DOI:10.1111/j.1468-1293.2009.00692.x